On this page
- If this is happening right now
- What the word “normal” on a lab report actually means
- Why Indian hearts break the reference range
- Lipoprotein(a) — the number your report doesn’t print
- Low HDL: the commoner Indian pattern
- Your number is not the lab’s number
- About statins — and about stopping them
- The daily aspirin question
- Getting it checked without making a project of it
- What a good follow-up looks like
- Related
- Frequently asked questions
If this is happening right now
If someone is having chest pain, pressure or heaviness at this moment — with sweating, breathlessness, vomiting, or pain spreading to the jaw, neck, back or left arm — stop reading and call 108. The ambulance is free, treatment begins on the road, and the network knows which centre is equipped for what that heart needs. Do not drive yourself, do not wait to see whether it settles, and do not let anyone call it gas trouble. A cholesterol report, however reassuring it looked last month, says nothing about what is happening in a chest today. Everything below this section is for the ordinary weeks in between.
What the word “normal” on a lab report actually means
Every lipid report prints a range beside your number, and the eye goes straight to it: inside the range, relief; outside, worry. But that range is a statistical description of a reference population — where most people’s values sat when the range was drawn up. It is not a statement about your arteries. A range answers the question is this number unusual? Your doctor is answering a different question: given this person’s age, diabetes, blood pressure, smoking and family history, what should this number be? Those two questions have different answers far more often than patients expect, and the distance between them is where a great many Indian heart attacks are quietly assembled.
Why Indian hearts break the reference range
Most of the ranges printed on Indian lab reports descend from studies done in Western populations, and South Asian bodies do not fit them neatly. Studies consistently show that Indians develop coronary artery disease at lower LDL levels, with less obvious risk on paper, and around a decade earlier than Western averages — men in their thirties and forties arrive in emergency rooms with a first heart attack nobody had been warned about. Then add what this district actually lives with: diabetes — sugar, as every household here says it — arriving early and often, blood pressure discovered late, and long days of work that contain very little walking. A number that looks unremarkable on the page can belong to a body already several years into the disease.
Lipoprotein(a) — the number your report doesn’t print
Lipoprotein(a), written Lp(a), is a cholesterol particle carried on a sticky protein tail that makes it more likely to lodge in an artery wall and to encourage clotting. It is set almost entirely by inheritance, it barely shifts with diet or exercise, and — this is the part that matters — it is not included in the standard lipid profile most people are handed. In South Asian study populations, around one in two people carries a raised Lp(a), a far higher share than in most Western groups. It is measured once in a lifetime, since the value hardly changes. A raised result does not mean a heart attack is coming. It means your other risks — LDL, blood pressure, sugar — deserve to be treated more firmly than the printed range suggests, and that your brothers, sisters and children deserve testing too.
Low HDL: the commoner Indian pattern
Ask most people what a bad cholesterol report looks like and they describe one very high total number. The commoner Indian picture is quieter: total cholesterol somewhere in the middle, LDL unremarkable, triglycerides drifting upward, and HDL — the fraction that carries cholesterol away from artery walls — sitting low. Low HDL with high triglycerides travels with insulin resistance, which is why it turns up so often in the person whose waistline has grown while the weighing scale barely moved. Almost none of this is visible if you read only the top line of the report. It responds, slowly and genuinely, to unglamorous things: walking every day, less refined starch at each meal, and treating the sugar and blood pressure that usually keep it company.
Your number is not the lab’s number
Two people can hand me the same LDL of 120 and walk out with opposite instructions. For a man of fifty with ten years of diabetes, a raised Lp(a) and a father who died at fifty-five, that number is too high and needs treating. For a healthy thirty-year-old with no other risk at all, it may need nothing more than a repeat next year and an honest look at how much he walks. This is what doctors mean by risk-based targets: the threshold moves with everything else about you, which is exactly what a printed range cannot do. So the useful question at the end of a consultation is not “is my report normal?” but “what should my LDL be, for me, and how are we going to get it there?” Write the answer on the report itself, so next year’s doctor sees it too.
About statins — and about stopping them
Statins are among the most studied medicines in circulation, and the evidence that they lower the risk of heart attack and stroke in people at raised risk is strong and consistent. They are prescribed after an assessment of your whole risk, not on the strength of a single number, and certainly not on the strength of a page like this one. Two requests, then. First, do not start one on your own — not from a relative’s leftover strip, not on a chemist’s suggestion; the decision takes in your liver, your kidneys, your other medicines and your actual risk. Second, do not stop one on your own either. Statins are abandoned far more often than they are ever started carelessly, usually after a forwarded message or a neighbour’s warning, and the risk returns quietly, without any symptom to announce it. If you have muscle aches or something you read has worried you, bring it to the consultation — most concerns have a straightforward answer, and where they do not, the medicine can be changed.
The daily aspirin question
A great many people over fifty here take a small aspirin every morning because somebody suggested it once and nobody has revisited it since. The guidance changed in 2019 and again in 2022: for people who have never had a heart attack or a stroke, routinely starting a daily aspirin is no longer advised, because the bleeding risk it carries can outweigh the protection it offers. That is a genuine reversal of earlier advice, not a technicality. For people who have already had a heart attack, a stent or certain kinds of stroke, aspirin remains important — and those patients should not stop it on their own. If you are swallowing an aspirin daily and cannot say which of those two groups you belong to, that is the single most useful thing to settle at your next visit.
Getting it checked without making a project of it
The test itself is undramatic: a fasting blood sample, results the same day, and a consultation that reads them against the rest of you rather than against a printed range. For families coming in from Kulasekharam or Colachel or across the border at Parassala, it fits inside one morning — the early bus, the sample, breakfast afterwards, the review. Bring your old reports, including the crumpled ones from two years ago, and the strips of every medicine you take, including anything started by another doctor. If chest symptoms are part of the story rather than a routine check, say so at the counter instead of sitting in the queue: PPK runs a 24-hour emergency service with intensive care and ventilator support, and a senior specialist is available for precisely that conversation.
What a good follow-up looks like
One report is a photograph; a series is a film, and the film is what tells you whether anything is actually changing. Keep every lipid profile in one folder with the date visible, and ask for three things at each review: what my LDL target is, whether Lp(a) is worth measuring once, and whether my blood pressure and sugar have been checked recently rather than assumed. Where diabetes runs in the family, an HbA1c belongs in the same visit — cholesterol and sugar rarely misbehave separately in Indian patients. And keep the dull work going through the year: a walk that survives the monsoon and a working week beats a perfect plan abandoned by June, in the same way that a rubber tapper’s five o’clock round beats a gym membership nobody uses.
Related
Frequently asked questions
Not worry — check. Normal means your number resembles a reference population's, not that your arteries are clear. If you have diabetes, high blood pressure, a family history of early heart disease, or you smoke, your personal target is likely lower than the printed range, and only a consultation can set it.
Lipoprotein(a) is an inherited cholesterol particle that lodges in artery walls more readily than ordinary LDL, and it is not measured in a standard lipid profile. Studies in South Asian populations find it raised in roughly one in two people. Because the level barely changes through life, one test is usually enough — ask your doctor whether yours is worth doing.
Low HDL is the commonest abnormal pattern on Indian lipid reports, and it is not harmless — it usually travels with rising triglycerides, an expanding waist and insulin resistance. No tablet reliably raises HDL. What moves it is daily walking, less refined starch at each meal, and treating the sugar and blood pressure that accompany it.
Statins are among the most studied medicines in use, and when prescribed after a proper assessment their benefit in preventing heart attacks and strokes outweighs their risks for people at raised risk. Muscle aches are the common complaint and can usually be settled by changing the medicine. Never start one on your own, and never stop one on your own — bring the worry to a consultation instead.
Not on your own initiative. Guidance changed in 2019 and again in 2022: for people who have never had a heart attack or stroke, routinely starting a daily aspirin is no longer advised, because the bleeding risk can outweigh the benefit. For those who have already had a heart attack, a stent or certain strokes, aspirin is usually important and must not be stopped without advice.